Transforming growth factor beta secretion from primary breast cancer fibroblasts

C. E.P. van Roozendaal, J. G.M. Klijn, B. van Ooijen, C. Claassen, A. M.M. Eggermont, S. C. Henzen-Logmans, J. A. Foekens

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

28 Citaten (Scopus)

Samenvatting

Transforming growth factor beta (TGF-β) is a hormonally regulated growth inhibitor with autocrine and/or paracrine functions in human breast cancer. In vivo, enhanced immunohistochemical staining of extracellular TGF-β1 has been detected around stromal fibroblasts in response to the antiestrogen treatment. We have investigated the effects of tamoxifen on the production of TGF-β by primary human breast fibroblast cultures in serum-free medium. Highly variable levels of mainly latent TGF-β1 were detected in conditioned media from both tumor and normal tissue derived fibroblasts. Hydroxy-tamoxifen was shown to increase latent TGF-β1 secretion in three of the eight tumor tissue-derived fibroblast cultures. Such effect of hydroxy-tamoxifen was not observed in fibroblast cultures established from normal adjacent breast tissue.

Originele taal-2Engels
Pagina's (van-tot)1-6
Aantal pagina's6
TijdschriftMolecular and Cellular Endocrinology
Volume111
Nummer van het tijdschrift1
DOI's
StatusGepubliceerd - 28 apr. 1995
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Transforming growth factor beta secretion from primary breast cancer fibroblasts'. Samen vormen ze een unieke vingerafdruk.

Citeer dit